Wednesday, July 8, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Patents matching “TENAX THERAPEUTICS, INC.”

4 pharma patents match "TENAX THERAPEUTICS, INC." in our USPTO index (A61K/A61P) — applicant, grant date, expiration, and drug links.

Matches 4
Index total 30,257
Page 1 / 1

Quick answer

This filtered view shows 4 pharmaceutical patents matching "TENAX THERAPEUTICS, INC." in our USPTO PatentsView index (CPC A61K/A61P). Search matches patent number, title, applicant, and CPC classification codes.

Patent results

4 results for “TENAX THERAPEUTICS, INC.” · 30,257 patents in full index Clear search

  1. US 11969424

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. · Granted Apr 30, 2024 · Expires Apr 25, 2044

    granted

  2. US 11701355

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. · Granted Jul 18, 2023 · Expires Jul 13, 2043

    granted

  3. US 11607412

    Levosimendan for treating pulmonary hypertension with heart failure with preserved ejection fraction (PH-HFpEF)

    TENAX THERAPEUTICS, INC. · Granted Mar 21, 2023 · Expires Mar 16, 2043

    granted

  4. US 11213524

    Pharmaceutical compositions for subcutaneous administration of levosimendan

    TENAX THERAPEUTICS, INC. · Granted Jan 4, 2022 · Expires Dec 30, 2041

    granted

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.